SEARCH

SEARCH BY CITATION

References

  • 1
    Nakashima, T., K. Okuda, M. Kojiro, A. Jimi, R. Yamaguchi, K. Sakamoto, et al. 1983. Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years. Cancer 51:863877.
  • 2
    Ikai, I., S. Arii, M. Okazaki, K. Okita, M. Omata, M. Kojiro, et al. 2007. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol. Res. 37:676691.
  • 3
    Nakayama, H., T. Takayama, M. Makuuchi, S. Yamasaki, T. Kosuge, K. Shimada, et al. 1999. Resection of peritoneal metastases from hepatocellular carcinoma. Hepatogastroenterology 46:10491052.
  • 4
    Hashimoto, M., K. Sasaki, J. Moriyama, M. Matsuda, and G. Watanabe. 2012. Resection of peritoneal metastases in patients with hepatocellular carcinoma. Surgery 153:727731.
  • 5
    Makino, I., S. Hojo, I. Terada, M. Note, K. Sawasaki, and H. Fujita. 2004. A case of peritoneal dissemination of ruptured hepatocellular carcinoma (HCC) resected three times [in Japanese]. J. Jpn Surg. Assoc. 65:13971402.
  • 6
    Eriguchi, N., S. Aoyagi, K. Okuda, T. Tamae, S. Fukuda, N. Kanazawa, et al. 2000. Successful surgical treatment for implanted intraperitoneal metastases of hepatocellular carcinoma. J. Hepatobiliary Pancreat. Surg. 7:520523.
  • 7
    Sonoda, T., T. Kanematsu, K. Takenaka, and K. Sugimachi. 1989. Ruptured hepatocellular carcinoma evokes risk of implanted metastases. J. Surg. Oncol. 41:183186.
  • 8
    Nishizaki, T., K. Takenaka, K. Yanaga, Y. Soejima, H. Uchiyama, K. Kishikawa, et al. 1997. Early detection of recurrent hepatocellular carcinoma. Hepatogastroenterology 44:508513.
  • 9
    Taketomi, A., T. Toshima, D. Kitagawa, T. Motomura, K. Takeishi, Y. Mano, et al. 2010. Predictors of extrahepatic recurrence after curative hepatectomy for hepatocellular carcinoma. Ann. Surg. Oncol. 17:27402746.
  • 10
    Llovet, J. M., S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J. F. Blanc, et al. 2008. Sorafenib in advanced hepatocellular carcinoma. N. Engl. J. Med. 359:378390.
  • 11
    Lin, C. C., H. P. Liang, H. S. Lee, G. T. Huang, P. M. Yang, M. C. Ho, et al. 2009. Clinical manifestations and survival of hepatocellular carcinoma patients with peritoneal metastasis. J. Gastroenterol. Hepatol. 24:815820.
  • 12
    Zhou, X. D., Y. Q. Yu, Z. Y. Tang, B. H. Yang, J. Z. Lu, Z. Y. Lin, et al. 1993. Surgical treatment of recurrent hepatocellular carcinoma. Hepatogastroenterology 40:333336.
  • 13
    Walkey, M. M., A. C. Friedman, P. Sohotra, and P. D. Radecki. 1988. CT manifestations of peritoneal carcinomatosis. AJR Am. J. Roentgenol. 150:10351041.
  • 14
    Yang, S. H., K. S. Suh, H. W. Lee, E. H. Cho, J. Y. Cho, Y. B. Cho, et al. 2006. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl. 12:16551660.
  • 15
    Lee, J. W., J. C. Paeng, K. W. Kang, H. W. Kwon, K. S. Suh, J. K. Chung, et al. 2009. Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J. Nucl. Med. 50:682687.
  • 16
    Yim, H. J., J. E. Yeon, K. S. Byun, C. H. Lee, S. Y. Choi, and S. K. Kim. 2008. Laparoscopic resection of HCC implanted in the peritoneal cavity: a case detected by PET after hepatic resection. Hepatogastroenterology 55:15491552.
  • 17
    Han, A. R., G. Y. Gwak, M. S. Choi, J. H. Lee, K. C. Koh, S. W. Paik, et al. 2009. The clinical value of 18F-FDG PET/CT for investigating unexplained serum AFP elevation following interventional therapy for hepatocellular carcinoma. Hepatogastroenterology 56:11111116.